Why the study?
To evaluate the connection between stroke and early-onset anxiety and depression, and assess several screening scales for detecting early symptoms.
Does ischemic stroke increase the risk of anxiety and depressive symptoms in the early post-stroke period compared to matched controls?
Does ischemic stroke increase the risk of anxiety and depressive symptoms in the early post-stroke period compared to matched controls?
Ischemic stroke is associated with significantly higher anxiety and depressive symptoms in the early post-stroke period (24 hours to 7 days) compared to matched controls.
Answers are grounded in this paper and cite their sources.
Early post-stroke anxiety/depression link may exist; leaves open causal confirmation and screening utility.
INTRODUCTION: There is some evidence suggesting an association between cerebrovascular diseases and the development of depression on the one hand, and between depression and post-stroke recovery on the other. Post-stroke depression can occur in the early post-stroke period or in the later stages of recovery (over 9 months after the incident). AIM: To find a connection between stroke and the development of anxiety and depression in the early period after the development of neurological deficit and to evaluate several scales for their potential usefulness in the screening of post-stroke patients for early signs of depression and anxiety. MATERIALS AND METHODS: We conducted a study on the presence of depression in 117 patients, divided into 2 groups: 73 of these patients were admitted due to ischemic stroke, while the other 44 were controls matching the patients in age, sex and education status. The inclusion and exclusion criteria were defined clearly. We included patients that consented to undergo psychiatric evaluation be-tween 24 hours and 7 days after the onset of neurological symptoms. Both groups were assessed by the Montgomery-Asberg Depression Rating Scale (MADRS), Hamilton Anxiety Rating Scale (HAM-A), Hospital Anxiety and Depression Scale - Depression Subscale and Combined Scale (HADS-D, HADS-T). RESULTS: On evaluation with HADS-D we noted the largest difference between the two groups with a very high statistical significance and a medium effect size (7.92±4.44 points vs. 4.86±4.27 points for the control group, p<0.001, r= -0.417). Anxiety and depressive symp-toms were found also with MADRS and HAM-A. CONCLUSIONS: Anxiety and depressive symptoms were found in the early post-stroke period. MADRS, HADS-D, and HAM-A are suf-ficiently specific and sensitive in the evaluation of post-stroke anxiety and depression.
No takes yet. Share an insight, caveat, or question.
Todorov et al. (2020) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: